- Home
- FTNT vs GSK Comparison
FTNT vs GSK Comparison
Compare FTNT & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FTNT | GSK |
|---|---|---|
| Founded | 2000 | 1715 |
| Country | United States | United Kingdom |
| Employees | N/A | 66841 |
| Industry | Computer peripheral equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 107.7B | 108.7B |
| IPO Year | 2009 | N/A |
Fundamental Metrics
Financial Performance| Metric | FTNT | GSK |
|---|---|---|
| Price | $163.73 | $52.52 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 25 | 2 |
| Target Price | ★ $85.71 | N/A |
| AVG Volume (30 Days) | ★ 5.9M | 3.8M |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 3.40% |
| EPS Growth | ★ 7.08 | N/A |
| EPS | ★ 0.72 | N/A |
| Revenue | ★ $6,799,600,000.00 | N/A |
| Revenue This Year | $14.02 | $6.99 |
| Revenue Next Year | $10.51 | $4.19 |
| P/E Ratio | $217.86 | ★ $32.75 |
| Revenue Growth | ★ 14.17 | N/A |
| 52 Week Low | $70.12 | $35.45 |
| 52 Week High | $163.57 | $61.70 |
Technical Indicators
Market Signals| Indicator | FTNT | GSK |
|---|---|---|
| Relative Strength Index (RSI) | 67.17 | 52.06 |
| Support Level | $76.64 | $49.93 |
| Resistance Level | N/A | $53.45 |
| Average True Range (ATR) | 6.43 | 1.01 |
| MACD | -0.12 | 0.09 |
| Stochastic Oscillator | 96.59 | 53.37 |
Price Performance
Historical ComparisonAbout FTNT Fortinet Inc.
Fortinet is a platform-based cybersecurity vendor with product offerings covering network security, cloud security, zero-trust access, and security operations. The firm derives a majority of its revenue through sales of its subscriptions and support-based business. The California-based firm has more than 800,000 customers across the world.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.